Mark Mulligan leads Emory swine flu vaccine trial. Interview by Brooke Grindlinger.
Mulligan
Mark
M
D000046:Academic Medical Centers; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks / Q000517:prevention & control; D005845:Georgia; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000276:immunology*; D007251:Influenza, Human / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D014481:United States / Q000453:epidemiology
D007252:Influenza Vaccines